- Home
- BMO vs BDX Comparison
BMO vs BDX Comparison
Compare BMO & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMO
- BDX
- Stock Information
- Founded
- BMO 1817
- BDX 1897
- Country
- BMO Canada
- BDX United States
- Employees
- BMO N/A
- BDX N/A
- Industry
- BMO Commercial Banks
- BDX Medical/Dental Instruments
- Sector
- BMO Finance
- BDX Health Care
- Exchange
- BMO Nasdaq
- BDX Nasdaq
- Market Cap
- BMO 73.7B
- BDX 66.1B
- IPO Year
- BMO N/A
- BDX 1962
- Fundamental
- Price
- BMO $97.60
- BDX $242.44
- Analyst Decision
- BMO Hold
- BDX Strong Buy
- Analyst Count
- BMO 5
- BDX 7
- Target Price
- BMO $128.00
- BDX $283.00
- AVG Volume (30 Days)
- BMO 588.3K
- BDX 2.0M
- Earning Date
- BMO 02-25-2025
- BDX 02-06-2025
- Dividend Yield
- BMO 4.55%
- BDX 1.71%
- EPS Growth
- BMO 65.10
- BDX 18.61
- EPS
- BMO 6.82
- BDX 5.86
- Revenue
- BMO $20,835,306,785.00
- BDX $20,178,000,000.00
- Revenue This Year
- BMO N/A
- BDX $10.12
- Revenue Next Year
- BMO $5.51
- BDX $5.02
- P/E Ratio
- BMO $14.30
- BDX $41.37
- Revenue Growth
- BMO 7.21
- BDX 4.16
- 52 Week Low
- BMO $76.98
- BDX $218.75
- 52 Week High
- BMO $104.63
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- BMO 44.01
- BDX 56.83
- Support Level
- BMO $92.99
- BDX $245.76
- Resistance Level
- BMO $100.87
- BDX $251.99
- Average True Range (ATR)
- BMO 1.48
- BDX 4.70
- MACD
- BMO -0.31
- BDX 0.21
- Stochastic Oscillator
- BMO 53.84
- BDX 60.75
About BMO Bank Of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, US P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.